Medytox Rises 5.15% Amid Botox (Botulinum Toxin) Theme Uptrend
On the 15th, the Botox (Botulinum toxin) theme rose 3.05% compared to the previous day, showing strength, while Medytox, a related stock drawing attention, surged 5.15% compared to the previous day. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.
[Graph] Major stock price changes in the Botox (Botulinum toxin) theme
According to the analysis by Thinkpool Robo Algorithm RASSI, Medytox’s quant financial score was 37.98 points, ranking 6th in the quant financial ranking within the Botox (Botulinum toxin) related theme. This can be interpreted as Medytox having relatively low investment attractiveness from a financial perspective. On the other hand, Huons Global ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.
[Table] Top stocks by financial score within the theme
※ The quant financial score is the result of the robo algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military: "Ceasefire Was an Opportunity to Strengthen Forces...We Treated It Like Wartime"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.